HOME >> BIOLOGY >> NEWS
Chemistry of alcoholism, vitamin C and stress addiction antibodies, futurefoods, preventing brain cell death, children's environmental health risks

NOTE TO REPORTERS, EDITORS AND PRODUCERS: The American Chemical Society, the world's largest scientific society, will hold its fall national meeting in New Orleans from August 22-26, 1999. ACS expects 12,000 registrants to attend sessions that will cover more than 5,600 papers on cutting-edge chemistry in topic areas including medicine, food, the environment, new materials, and more. Following is advance information provided to assist you in planning coverage of the meeting; a complete final program is attached. Please note that all of the enclosed material is EMBARGOED FOR RELEASE until the date and time of presentation, and that the times of day provided are Central Time.

All news releases and advisories for this ACS national meeting will be posted on the Eurekalert! website at www.eurekalert.org , with embargoed advance material available to registered journalists. We expect to have more detailed information - including a complete set of meeting abstracts, news releases on selected sessions, and a schedule of news briefings - closer to the meeting start date. All releases also will be posted on the ACS web site at www.acs.org/meetings/neworleans/ once the embargo is lifted. For more information contact: Nancy Blount at 202/872-4440 or Charmayne Marsh at 202/872-4445. After August 18, contact the ACS Newsroom in New Orleans at 504/681-5452 or 504/670-7646 from 7 a.m. to 6 p.m. Central Time.

Sunday, August 22:

Food for the Next Millenium: A major symposium will explore a wide range of research into the chemistry of forthcoming foods and how their production, processing and delivery is expected to change in the next millenium. Examples of future foods will be presented as well as a chef's perspective on how chemistry impacts the pleasure of eating. (See page 62, Presidential Event 1-7, Sunday, August 22, 8:30 a.m. in the final program).

Vitamin C
'"/>

Contact: Charmayne Marsh
y_marsh@acs.org
202-872-4445
American Chemical Society
22-Aug-1999


Page: 1 2 3 4

Related biology news :

1. Chemistry meets Biology
2. Roderick MacKinnon wins 2003 Nobel Prize in Chemistry
3. DuPont receives US EPAs Presidential Green Chemistry Award for new innovation
4. Organic & Biomolecular Chemistry
5. UT Southwestern researcher honored as winner of AstraZeneca Excellence in Chemistry Award
6. Kurt Wthrich of The Scripps Research Institute wins 2002 Nobel Prize in Chemistry
7. Chemistry of tanning
8. Harden McConnell named winner of 2002 Welch Award in Chemistry
9. Chemistry of life in outer space is topic of two-day symposium, April 4-5
10. Chemistry in the Amazon: Tropical birds, Amazonian tribespeople derive medicinal benefits from insects, plants
11. Chemistry to play major role in solving 21st century challenges

Post Your Comments:
(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...
(Date:5/21/2013)... a class of pharmaceuticals can both prevent and treat ... as "TSPO ligands," are currently used for certain types ... TSPO ligand in young adult mice when pathology was ... pathology was quite severe," said lead researcher Christian Pike ... reduced measures of pathology and improved behavior at both ...
(Date:5/21/2013)... all types become most deadly when they metastasize and ... this stage, it becomes very difficult for doctors to ... Now, researchers at the University of Missouri have found ... tumor cells wherever they may be in the body. ... MU College of Veterinary Medicine, says being able to ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Drugs found to both prevent and treat Alzheimer's disease in mice 2MU researchers develop radioactive nanoparticles that target cancer cells 2
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, ... that Genzyme, a Sanofi company and leading biotech company, ... for a multi-use facility in the United States. With ... buildings, this latest order underscores the satisfaction and success ... device improving doorway access control. , “We ...
(Date:5/21/2013)... Md. , May 21, 2013  MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM.  The presentation ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: